Gabriele Schaefer

3.4k total citations · 1 hit paper
31 papers, 1.7k citations indexed

About

Gabriele Schaefer is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gabriele Schaefer has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Oncology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gabriele Schaefer's work include Monoclonal and Polyclonal Antibodies Research (16 papers), HER2/EGFR in Cancer Research (13 papers) and Glycosylation and Glycoproteins Research (6 papers). Gabriele Schaefer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), HER2/EGFR in Cancer Research (13 papers) and Glycosylation and Glycoproteins Research (6 papers). Gabriele Schaefer collaborates with scholars based in United States, France and Germany. Gabriele Schaefer's co-authors include Mark X. Sliwkowski, Robert W. Akita, Vincent Fitzpatrick, Richard Vandlen, Richard A. Cerione, Kermit L. Carraway, Andrew Nuijens, B M Fendly, Lihua Shao and Sara Birtalan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Immunology.

In The Last Decade

Gabriele Schaefer

31 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

1994 560 citations Mark X. Sliwkowski, Gabriele Schaefer et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabriele Schaefer United States	17	900	899	784	241	168	31	1.7k
Michael T. Lipari United States	21	861 1.0×	525 0.6×	483 0.6×	213 0.9×	127 0.8×	26	1.8k
Natalia Jura United States	25	2.1k 2.3×	1.3k 1.4×	711 0.9×	237 1.0×	375 2.2×	50	3.2k
Fangtian Huang United States	12	1.6k 1.8×	494 0.5×	302 0.4×	187 0.8×	92 0.5×	12	2.1k
Meizhen Lou Australia	13	1.2k 1.4×	1.1k 1.2×	852 1.1×	353 1.5×	168 1.0×	18	2.1k
Jordan A. Krall United States	8	1.0k 1.1×	895 1.0×	261 0.3×	424 1.8×	142 0.8×	8	1.9k
Alan Berezov United States	19	1000 1.1×	721 0.8×	465 0.6×	293 1.2×	189 1.1×	33	1.8k
Francisca Maurer Switzerland	10	1.4k 1.5×	900 1.0×	388 0.5×	141 0.6×	146 0.9×	15	2.1k
M J Glennie United Kingdom	17	857 1.0×	578 0.6×	867 1.1×	764 3.2×	173 1.0×	25	2.2k
Anne E.G. Lenferink Canada	18	1.3k 1.4×	1.1k 1.2×	423 0.5×	130 0.5×	233 1.4×	43	2.0k
Hans W. Christinger United States	14	2.0k 2.3×	501 0.6×	660 0.8×	425 1.8×	67 0.4×	15	2.6k

Countries citing papers authored by Gabriele Schaefer

Since Specialization

Citations

This map shows the geographic impact of Gabriele Schaefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriele Schaefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriele Schaefer more than expected).

Fields of papers citing papers by Gabriele Schaefer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriele Schaefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriele Schaefer. The network helps show where Gabriele Schaefer may publish in the future.

Co-authorship network of co-authors of Gabriele Schaefer

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriele Schaefer. A scholar is included among the top collaborators of Gabriele Schaefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriele Schaefer. Gabriele Schaefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mutch, David G., Athina Voulgari, Xian Chen, et al.. (2024). Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti–PD‐L1, for BRCA wild‐type, platinum‐sensitive, recurrent ovarian cancer. Cancer. 130(11). 1940–1951. 2 indexed citations

Chan, Jocelyn, Lily Shao, Scott Stawicki, et al.. (2022). Systematic pharmacological analysis of agonistic and antagonistic fibroblast growth factor receptor 1 MAbs reveals a similar unique mode of action. Journal of Biological Chemistry. 299(1). 102729–102729. 1 indexed citations

Hegde, Ganapati V., Jennifer M. Giltnane, Lisa Crocker, et al.. (2019). NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma. eLife. 8. 9 indexed citations

Lee, Ho‐Young, et al.. (2017). “Two-in-One” approach for bioassay selection for dual specificity antibodies. Journal of Immunological Methods. 448. 74–79. 10 indexed citations

Kirouac, Daniel C., Gabriele Schaefer, Jocelyn Chan, et al.. (2017). Clinical responses to ERK inhibition in BRAF V600E-mutant colorectal cancer predicted using a computational model. npj Systems Biology and Applications. 3(1). 14–14. 50 indexed citations

Chung, Inhee, Mike Reichelt, Lily Shao, et al.. (2016). High cell-surface density of HER2 deforms cell membranes. Nature Communications. 7(1). 12742–12742. 57 indexed citations

Hanan, Emily J., Marian C. Bryan, Yuan Chen, et al.. (2015). 4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 26(2). 534–539. 39 indexed citations

Phillips, Gail D. Lewis, Carter T. Fields, Guangmin Li, et al.. (2013). Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy. Clinical Cancer Research. 20(2). 456–468. 148 indexed citations

Lee, Ho‐June, Gabriele Schaefer, Timothy P. Heffron, et al.. (2012). Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M. Cancer Discovery. 3(2). 168–181. 68 indexed citations

10.

Scheer, Justin M., Wendy Sandoval, J. Michael Elliott, et al.. (2012). Reorienting the Fab Domains of Trastuzumab Results in Potent HER2 Activators. PLoS ONE. 7(12). e51817–e51817. 32 indexed citations

11.

Wranik, Bernd J., et al.. (2012). LUZ-Y, a Novel Platform for the Mammalian Cell Production of Full-length IgG-bispecific Antibodies. Journal of Biological Chemistry. 287(52). 43331–43339. 29 indexed citations

12.

Kamath, Amrita V., Dan Lu, Priyanka Gupta, et al.. (2011). Preclinical pharmacokinetics of MEHD7945A, a novel EGFR/HER3 dual-action antibody, and prediction of its human pharmacokinetics and efficacious clinical dose. Cancer Chemotherapy and Pharmacology. 69(4). 1063–1069. 32 indexed citations

13.

Fisher, Robert D., Mark Ultsch, Andreas Lingel, et al.. (2010). Structure of the Complex between HER2 and an Antibody Paratope Formed by Side Chains from Tryptophan and Serine. Journal of Molecular Biology. 402(1). 217–229. 43 indexed citations

14.

Birtalan, Sara, Yingnan Zhang, Frédéric A. Fellouse, et al.. (2008). The Intrinsic Contributions of Tyrosine, Serine, Glycine and Arginine to the Affinity and Specificity of Antibodies. Journal of Molecular Biology. 377(5). 1518–1528. 189 indexed citations

15.

Schaefer, Gabriele, Chandrasekhar Venkataraman, & Ulrike Schindler. (2001). Cutting Edge: FISP (IL-4-Induced Secreted Protein), a Novel Cytokine-Like Molecule Secreted by Th2 Cells. The Journal of Immunology. 166(10). 5859–5863. 71 indexed citations

16.

Penuel, Elicia, Gabriele Schaefer, Robert W. Akita, & Mark X. Sliwkowski. (2001). Structural requirements for ErbB2 transactivation. Seminars in Oncology. 28(6 Suppl 18). 36–42. 2 indexed citations

17.

Schaefer, Gabriele, Robert W. Akita, & Mark X. Sliwkowski. (1999). A Discrete Three-amino Acid Segment (LVI) at the C-terminal End of Kinase-impaired ErbB3 Is Required for Transactivation of ErbB2. Journal of Biological Chemistry. 274(2). 859–866. 30 indexed citations

18.

Schaefer, Gabriele, Vincent Fitzpatrick, & Mark X. Sliwkowski. (1997). γ-Heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. Oncogene. 15(12). 1385–1394. 80 indexed citations

19.

Sliwkowski, Mark X., Gabriele Schaefer, Robert W. Akita, et al.. (1994). Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.. Journal of Biological Chemistry. 269(20). 14661–14665. 560 indexed citations breakdown →

20.

Schaefer, Gabriele, et al.. (1956). [Variability of aldolase in cattle crystalline lens].. PubMed. 158(2). 182–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact